FDA Guidance Documents·· 原文未提供具体时分
Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations: Guidance for Sponsors, Investigators, and Institutional Review Boards
Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations: Guidance for Sponsors, Investigators, and Institutional Review Boards
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2018-10-11。官方主题：Good Clinical Practice (GCP)。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov